Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 28

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 28
---
 use cases. The AI COE ensures these use cases align with our Responsible AI Principles and adhere to health care privacy and security requirements.

The Cigna Group Board oversees and receives updates on our technology strategy, including the use, ethics, and governance of AI.

Shareholder Engagement

The Board and the Corporate Governance Committee oversee the Company’s shareholder engagement practices. Our engagement with shareholders helps us better understand our shareholders’ priorities and perspectives, continue to develop strong relationships, and ensures the Board considers concerns that our shareholders may have. The Board considers feedback and insights from our shareholders as it reviews and evolves our governance and executive compensation practices and disclosures.

Our Corporate Secretary, our Senior Vice President of Investor Relations, and representatives of The Cigna Group Office of the Corporate Secretary, Executive Compensation, and Environmental, Social, and Governance teams conduct meetings to update investors and regularly convey feedback from those meetings to the Chair of the Board,

| 34 |     | The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |

| CORPORATE GOVERNANCE MATTERS |

our Lead Independent Director, and other members of the Board and management. We engage with shareholders throughout the year on a number of topics related to corporate governance, executive compensation, corporate responsibility, Company performance, and other areas of focus for shareholders. Sine the filing of our 2024 proxy statement, we engaged on governance-related topics with holders of approximately 30% of our outstanding stock. (1)

| In 2024, we invited holders of approximately 70% of our outstanding stock, including our 100 largest shareholders, to engage with us to discuss governance-related topics.(1) |

(1) Based on holdings as of Decemb er 31, 2024.

| Governance-Related Topics                   |     |                                   |     |                        |     |                       |     |                                                      |
| Corporate governance and shareholder rights |     | Board composition and refreshment |     | Executive compensation |     | Human capital matters |     | Environmental and social initiatives and performance |

The robust shareholder engagement program at The Cigna Group is designed to foster an active and constructive dialogue with a broad and representative group of our shareholders. The Cigna Group believes that our engagement practices strengthen our relationships with our shareholders and underscore our commitment to acting in the best interests of the Company’s shareholders and other stakeholders.

Our engagement with shareholders continues to influence our policies and practices. We have implemented several governance and disclosure enhancements for which shareholders have expressed support in our engagement discussions, including